Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Heart Function in People Receiving an LVAD
Status:
Terminated
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
Left ventricular assist devices (LVADs) are one treatment option for people with congestive
heart failure. This study will evaluate the safety of injecting mesenchymal precursor cells
(MPCs) into the heart during LVAD implantation surgery and examine if injecting MPCs into the
heart is effective at improving heart function.
Phase:
Phase 2
Details
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Collaborators:
Angioblast Systems National Heart, Lung, and Blood Institute (NHLBI)